Bristol-Myers Squibb
BMY
#186
Rank
NZ$189.47 B
Marketcap
NZ$93.07
Share price
-0.58%
Change (1 day)
-0.46%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.12. In 2024 the company made an earnings per share (EPS) of NZ-$7.62 a decrease over its 2023 EPS that were of NZ$6.69.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-167.16%
2024NZ-$7.62-213.92%
2023NZ$6.6930.2%
2022NZ$5.14-6.04%
2021NZ$5.47-179.29%
2020NZ-$6.90-281.37%
2019NZ$3.80-27.21%
2018NZ$5.22
2016NZ$4.60175.26%
2015NZ$1.67-19.83%
2014NZ$2.09-22.44%
2013NZ$2.6934.48%
2012NZ$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.97-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.09 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.38 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.69 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$6.39 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
NZ$5.23 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$18.00 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.33-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.47 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.95 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA